A target cell is any cell in the body that responds to a particular chemical signal because it carries the matching receptor for that signal. In endocrinology, the term refers to cells that hormones act on; in immunology, it refers to cells marked for destruction by killer lymphocytes; and in hematology, it describes a red blood cell with a distinctive bullseye appearance under the microscope. The phrase “target cell” turns up across nearly every branch of biology, and the specific meaning shifts with the context, which can be confusing if you encounter it without that framing.
What Makes a Cell a “Target”
The core idea is simple: a signaling molecule floating through the bloodstream, diffusing across a tissue, or sitting on the surface of a neighboring cell can only affect a cell that has the right receptor. Billions of cells may be bathed in the same hormone, but only those displaying the corresponding receptor protein will respond. The number of receptors on a given cell is not fixed, either. Receptor concentration appears to be one of the main variables that determines how strongly and how long a hormone’s effects last, and that concentration is itself controlled by hormonal signals, including the very hormone being received.1PubMed. Hormone receptors and target cell responsiveness So a target cell is not a passive recipient; it actively tunes how loudly it “hears” each signal.
This receptor-based selectivity explains why a single hormone can circulate everywhere yet produce effects in only a few tissues. Insulin, for example, binds a receptor on the surface of muscle, liver, and fat cells, kicking off a chain of internal signals that tell those cells to take up glucose and store energy.2PubMed Central. Mechanisms of Insulin Action and Insulin Resistance Cells that lack the insulin receptor are essentially invisible to it. The receptor is the lock; the hormone is the key. No lock, no response.
Target Cells in Hormone Signaling
Hormones reach their targets by two broad routes. Peptide hormones and many growth factors bind receptors embedded in the cell’s outer membrane, triggering a cascade of chemical events inside the cell within seconds to minutes. Steroid hormones take a different path: they slip through the cell membrane and bind receptors inside the cell, which then travel to the nucleus and directly alter which genes are switched on or off.3PubMed. Rapid actions of steroid receptors in cellular signaling pathways This distinction matters because the two mechanisms produce responses on very different timescales. A burst of adrenaline hitting a heart-muscle cell’s surface receptor can speed up your heartbeat in seconds, while a steroid like cortisol reshaping gene activity in a liver cell takes hours.
Insulin offers a useful case study. When insulin binds its receptor on the plasma membrane of a target cell, the receptor activates a series of downstream proteins that ultimately open glucose-transporting channels and shift the cell’s metabolism toward energy storage.4Signal Transduction and Targeted Therapy. Trends in insulin resistance: insights into mechanisms and therapeutic strategy In type 2 diabetes, the target cells still carry the receptor, but their internal signaling pathway becomes sluggish, so the message is received but poorly acted upon. That is an example of a target cell losing responsiveness without losing the receptor itself, a reminder that being a “target” does not guarantee a healthy response.
How Target Cells Fine-Tune Their Own Sensitivity
Target cells do not just passively wait for signals. They adjust how many receptors they display and how sensitive those receptors are. When a cell is flooded with a signal for a long period, it can pull receptors off its surface through a process called downregulation, or it can chemically modify them so they respond less vigorously, a process called desensitization. Modeling work has shown that these mechanisms actually sharpen the cell’s ability to process incoming signals, widening the range of signal frequencies the cell can decode rather than simply muting everything.5PubMed Central. Receptor downregulation and desensitization enhance the information processing ability of signalling receptors
This is why chronic exposure to a drug or hormone sometimes leads to tolerance: the target cells have dialed down their receptor population or sensitivity so that the same dose produces a weaker effect. It is also why abruptly stopping certain medications can cause rebound symptoms, because the cells have been running with fewer receptors and need time to ramp back up.
Target Cells in the Immune System
In immunology, “target cell” flips the script. Here it means a cell that is about to be killed. Virus-infected cells, cancer cells, and transplanted foreign cells can all become targets when the immune system identifies them as threats. The main executioners are cytotoxic T cells and natural killer (NK) cells, which destroy targets through a shared weapon: perforin, a protein that punches holes in the target cell’s membrane. Once perforin molecules polymerize and form channels in the membrane, they allow ions, water, and destructive enzymes to flood through, collapsing the cell’s internal environment and killing it.6PubMed Central. Perforin: an important player in immune response
How do NK cells decide what to kill? One influential idea is the “missing self” hypothesis: NK cells patrol the body looking for cells that have lost the identity markers normally found on healthy cells. When a cell fails to display these markers, NK cells treat it as a target and attack.7PubMed. In search of the ‘missing self’: MHC molecules and NK cell recognition Many viruses and cancers deliberately downregulate those markers to dodge detection by T cells, which inadvertently makes them visible to NK cells instead. It is an elegant backup system.
Exploiting Target Cells in Cancer Therapy
Modern cancer treatment increasingly revolves around redirecting the immune system’s targeting machinery. CAR T cell therapy, for instance, engineers a patient’s own immune cells to recognize specific proteins on cancer cells. In a recent trial targeting two proteins found on the surface of multiple myeloma cells, the engineered T cells selectively killed cancer cells displaying either protein while leaving normal tissue largely alone.8PubMed Central. Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial The precision comes from forcing the therapeutic cells to treat cancer cells as their targets through an artificial receptor.
The flip side of that precision is off-target toxicity. Antibody-drug conjugates, which are antibodies linked to a toxic payload, are designed to deliver their poison only to cells carrying a specific surface marker. But the sugar molecules decorating the antibody can sometimes be grabbed by receptors on unintended cells, dragging the toxic cargo into healthy tissue. One proposed mechanism involves a lectin receptor that binds certain sugar patterns on the antibody and internalizes it into liver, spleen, and immune cells that were never the intended targets.9PubMed Central. Proposed mechanism of off-target toxicity for antibody-drug conjugates driven by mannose receptor uptake In that scenario, healthy cells accidentally become target cells for the drug.
Target Cells in Virology
Viruses, like hormones, need a receptor to enter a cell. HIV provides one of the best-studied examples. The virus carries a surface protein that binds a molecule called CD4 on certain immune cells, along with a co-receptor, and those interactions trigger the fusion of viral and cell membranes, letting the virus slip inside.10PubMed. Cell surface receptors, virus entry and tropism of primate lentiviruses The cells that display both CD4 and the right co-receptor are the target cells for HIV, which is why the virus primarily infects a subset of immune cells rather than, say, muscle or bone.
This principle extends to virtually every virus. The cold virus latches onto receptors in the upper respiratory tract; hepatitis viruses target liver cells because of the receptors those cells carry. Understanding which cells a virus targets explains its symptoms, its tissue damage, and often its route of transmission.
Target Cells on a Blood Smear
The hematological meaning of “target cell” is entirely different from everything above. In this context, a target cell (also called a codocyte or leptocyte) is a red blood cell that, when stained and viewed under a microscope, looks like an archery target: a dark center, a pale ring, and then a dark outer ring. This appearance has nothing to do with signaling or receptors. It is a consequence of the cell having more membrane surface area than its volume requires, so the membrane bunches up in the center when the cell lies flat on a slide.
What causes that extra surface area? Often it comes down to cholesterol. In obstructive jaundice, elevated bile salts in the blood cause red blood cell membranes to accumulate cholesterol, increasing their surface area and producing the flattened shape and bullseye look characteristic of target cells. These cells also become more resistant to bursting in dilute solutions, because the extra membrane gives them more room to swell.11JCI Insight. Bile salts and cholesterol in the pathogenesis of target cells in obstructive jaundice Measurements confirm that target cells carry a higher ratio of cholesterol to phospholipids in their membranes compared with normal red blood cells.12PubMed Central. Membrane lipid composition of red blood cells in liver disease: regression of spur cell anaemia after infusion of polyunsaturated phosphatidylcholine
Target cells on a blood smear can also form when a normal volume of cell contents is enclosed in a membrane that became too large for other reasons. This happens after spleen removal, possibly because the spleen normally trims excess membrane from maturing red blood cells.13Blood. The Pathogenesis of Spherocytes and Leptocytes (Target Cells)
When Seeing Target Cells on a Smear Matters Clinically
If a lab technician spots target cells during a routine blood test, it is not a diagnosis on its own but a clue. The conditions most commonly associated with target cells fall into a few broad categories:
- Liver disease: Obstructive jaundice, cirrhosis, and other conditions that alter bile salt or lipid metabolism can increase membrane cholesterol and produce target cells.
- Hemoglobin disorders: Certain inherited hemoglobin variants are strongly associated with target cells. Hemoglobin C disease is a notable example; blood smear analysis shows target cells predominantly in people who carry two copies of the hemoglobin C gene.14PubMed Central. Hematological Profile of Hemoglobin C Disease: A Retrospective Study Thalassemias also frequently produce target cells.
- Iron deficiency: Severe iron deficiency can lead to red blood cells with less hemoglobin and a relative excess of membrane, creating the target appearance.
- Post-splenectomy: Without the spleen’s role in remodeling red blood cell membranes, target cells often appear in the circulation.
Clinicians use the presence of target cells alongside other findings, such as cell counts and hemoglobin levels, to narrow down the cause. Target cells alone are not alarming, but they prompt further investigation when they appear unexpectedly.
Target Cells in Plant Biology
The concept of target cells is not limited to animals. Plants rely heavily on hormones to coordinate growth, flowering, and stress responses, and those hormones act on specific target cells just as animal hormones do. Guard cells, the pair of cells flanking each pore (stoma) on a leaf surface, are classic target cells for the plant hormone abscisic acid (ABA). When conditions become dry, ABA levels rise and act on guard cells to close the stomatal pores, reducing water loss.15PubMed Central. Abscisic acid signal transduction in guard cells is mediated by phospholipase D activity
Interestingly, this ABA-guard cell relationship is not universal across all land plants. In seed plants, high ABA levels in the leaf prevent stomata from reopening rapidly, but ferns and their relatives show different sensitivity to the hormone.16PubMed Central. Fern and lycophyte guard cells do not respond to endogenous abscisic acid The guard cells of ferns are structurally similar to those of flowering plants, yet they do not respond to ABA in the same way, suggesting that the target-cell relationship between ABA and guard cells evolved after the lineages diverged. It is a good reminder that whether a cell counts as a “target” for a particular signal is not a fixed feature of biology; it is shaped by evolutionary history.
Target Cells During Embryonic Development
During the earliest stages of an embryo’s formation, cells need to know where they are in order to become the right tissue type. Signaling molecules called morphogens spread out from a source and form a concentration gradient. Cells closer to the source receive a stronger signal; cells farther away receive a weaker one. Each cell reads the concentration it encounters and activates a particular set of genes in response, effectively being told “you are here” in the developing body plan.17PubMed Central. Morphogen gradients in development: from form to function
This is not a simple threshold story, though. Research on the morphogen Nodal in zebrafish embryos found that it is not just the concentration of the signal that matters, but also how long a cell is exposed. Two groups of target cells can experience the same signal intensity at a given moment, yet express different genes depending on whether they have been bathed in that signal for one hour or two. That means cells interpret both the strength and the duration of the signal to decide their fate.18eLife. Response to Nodal morphogen gradient is determined by the kinetics of target gene induction
Even a cell’s physical size can play a role. In Notch signaling, where neighboring cells directly exchange signals through surface-bound proteins, mathematical modeling predicts that smaller cells tend to adopt one fate while larger cells adopt another, because the amount of contact area between cells influences how much signal is transmitted.19Developmental Cell. Dependence of Notch Signaling on Cell-Cell Contact Area Dictates Cell Fate Decisions So a developing cell’s response depends on its receptor inventory, the signal’s concentration, the duration of exposure, and even its geometry.
How Receptors Evolved to Create New Target Cells
One of the more fascinating threads in this story is how target-cell relationships originate over evolutionary time. Modern vertebrates have separate receptors for the stress hormone cortisol and the salt-balance hormone aldosterone, and these receptors sit in different target tissues doing different jobs. But both receptors descend from a single ancestral receptor found in jawless fish like lampreys, which responds to both hormones. Distinct versions of the receptor first appeared in cartilaginous fish like sharks and skates, allowing different tissues to respond selectively to one hormone or the other.20PubMed. Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors
The duplication and divergence of receptor genes is one of the main ways new target-cell populations arise. When a receptor gene duplicates, one copy can mutate and specialize for a slightly different signal or be expressed in a different tissue, effectively turning a previously unresponsive cell into a new target. Over hundreds of millions of years, this process has generated the extraordinarily complex signaling networks that coordinate everything from blood sugar to embryonic patterning.
Neurotransmitter-Receptor Matching in Muscle
The nervous system provides yet another angle on the target-cell concept. At the junction where a nerve meets a muscle fiber, the muscle cell must display the right receptor for the neurotransmitter the nerve is releasing; otherwise, the signal to contract would go unheard. During early development in vertebrate embryos, muscle cells actually express receptors for several different neurotransmitters at once, but as maturation proceeds, one type wins out. In experiments where normal patterns of neural activity were disrupted, the receptor populations on muscle cells shifted to match whichever neurotransmitter the nerve was now releasing, and functional synapses using those alternative transmitters formed.21PubMed Central. Activity-dependent neurotransmitter-receptor matching at the neuromuscular junction The muscle cell, in other words, adjusted which signal it was a target for, based on what its nerve partner was actually sending. That kind of plasticity blurs the line between “target” and “collaborator” and hints at a more dynamic relationship than the simple lock-and-key image might suggest.